CRMD
HealthcareCorMedix Inc.
$6.42+0.03 (+0.39%)
Prev Close
$6.40
Open
$6.40
High
$6.49
Low
$6.22
Volume
1.43M
Market Cap
$515.7M
P/E
3.09
Div Yield
—
Over the past 12 months, insider activity at CorMedix Inc. (CRMD) has been dominated by selling, with 1 insider purchase totaling $275.5K and 22 insider sales totaling $6.12M. The most recent insider transaction was by Blum Susan (Chief Financial Officer), who sold $71.0K worth of shares on Jan 23, 2026. CorMedix Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $515.7M.
Buys (12M)
1
$275.5K
Sells (12M)
22
$6.12M
Net Activity
Net Seller
$5.85M
Active Insiders
8
last 12 mo
CRMD Price Chart
CRMD Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026↗ | Blum Susan | Chief Financial Officer | Sell | 9,767 | $7.27 | $71.0K | 0 |
| Jan 23, 2026↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 10,778 | $7.27 | $78.4K | 0 |
| Jan 23, 2026↗ | Todisco Joseph | Chief Executive Officer | Sell | 27,306 | $7.27 | $198.5K | 0 |
| Jan 23, 2026↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 8,803 | $7.27 | $64.0K | 0 |
| Jan 22, 2026↗ | Dillione Janet | director | Sell | 10,000 | $6.88 | $68.8K | 38,473 |
| Jan 21, 2026↗ | Dillione Janet | Director | Sell | 10,000 | $6.88 | $68.8K | 0 |
| Jan 12, 2026↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 5,794 | $7.15 | $41.4K | 0 |
| Jan 12, 2026↗ | Todisco Joseph | Chief Executive Officer | Sell | 40,082 | $6.94 | $278.2K | 0 |
| Jan 2, 2026↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 10,895 | $12.16 | $132.5K | 0 |
| Jan 2, 2026↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 11,333 | $12.16 | $137.8K | 0 |
| Dec 30, 2025↗ | DUNTON ALAN W | Director | Sell | 20,000 | $13.00 | $260.0K | 0 |
| Dec 18, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 30,000 | $12.00 | $360.0K | 0 |
| Dec 9, 2025↗ | Dillione Janet | Director | Sell | 34,000 | $12.00 | $408.0K | 0 |
| Dec 9, 2025↗ | Lefkowitz Steven W | Director | Sell | 40,000 | $11.88 | $475.2K | 0 |
| Dec 2, 2025↗ | Dillione Janet | Director | Sell | 46,657 | $10.00 | $466.6K | 0 |
| Nov 24, 2025↗ | Dillione Janet | Director | Sell | 26,343 | $9.93 | $261.6K | 0 |
| Nov 14, 2025↗ | Dillione Janet | Director | Sell | 30,000 | $11.42 | $342.6K | 0 |
| Oct 23, 2025↗ | Kaplan Myron | Director | Buy | 25,000 | $11.02 | $275.5K | 0 |
| Sep 12, 2025↗ | DUNTON ALAN W | Director | Sell | 10,000 | $13.13 | $131.3K | 0 |
| Sep 12, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 50,000 | $13.00 | $650.0K | 0 |
| Sep 9, 2025↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 53,997 | $13.18 | $711.8K | 0 |
| Sep 9, 2025↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 50,000 | $13.41 | $670.3K | 0 |
| May 10, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 21,225 | $11.66 | $247.5K | 0 |
| Jan 17, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 23,977 | $12.17 | $291.8K | 0 |
| Jan 10, 2025↗ | David Matthew T | Chief Financial Officer | Sell | 6,515 | $11.19 | $72.9K | 0 |
| Jan 10, 2025↗ | Hurlburt Elizabeth | EVP | Sell | 5,790 | $11.19 | $64.8K | 0 |
| Jan 10, 2025↗ | Mistry Erin | EVP, Chief Commercial Officer | Sell | 5,689 | $11.19 | $63.7K | 0 |
| Jan 10, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 17,829 | $11.19 | $199.5K | 0 |
| Jan 2, 2025↗ | David Matthew T | Chief Financial Officer | Sell | 8,648 | $8.22 | $71.1K | 0 |
| Jan 2, 2025↗ | Hurlburt Elizabeth | EVP | Sell | 11,378 | $8.22 | $93.5K | 0 |
| Jan 2, 2025↗ | Mistry Erin | EVP, Chief Commercial Officer | Sell | 7,830 | $8.22 | $64.4K | 0 |
| Jan 2, 2025↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 11,844 | $8.22 | $97.4K | 0 |
| Dec 12, 2024↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 6,044 | $8.77 | $53.0K | 0 |
| Nov 14, 2024↗ | Hurlburt Elizabeth | EVP | Sell | 140,027 | $11.18 | $1.57M | 0 |
| Oct 31, 2024↗ | Mistry Erin | EVP, Chief Commercial Officer | Buy | 1,500 | $9.99 | $15.0K | 0 |
| May 10, 2024↗ | Todisco Joseph | Chief Executive Officer | Sell | 26,982 | $5.17 | $139.5K | 0 |
| Mar 13, 2024↗ | Todisco Joseph | Chief Executive Officer | Buy | 13,561 | $3.74 | $50.7K | 0 |
| Jan 12, 2024↗ | David Matthew T | Chief Financial Officer | Sell | 5,216 | $3.47 | $18.1K | 0 |
| Jan 12, 2024↗ | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | Sell | 4,603 | $3.47 | $16.0K | 0 |
| Jan 12, 2024↗ | Mistry Erin | Chief Commercial Officer | Sell | 4,389 | $3.47 | $15.2K | 0 |
| Jan 12, 2024↗ | Todisco Joseph | Chief Executive Officer | Sell | 13,781 | $3.47 | $47.8K | 0 |
| Dec 14, 2023↗ | DUNTON ALAN W | Director | Buy | 6,000 | $3.38 | $20.3K | 0 |
| Nov 17, 2023↗ | Mistry Erin | Chief Commercial Officer | Buy | 1,000 | $4.00 | $4.0K | 0 |
| Sep 8, 2023↗ | Todisco Joseph | Chief Executive Officer | Buy | 10,000 | $3.71 | $37.1K | 0 |
| May 18, 2023↗ | Kaplan Myron | Director | Buy | 6,000 | $4.54 | $27.3K | 0 |
| May 10, 2023↗ | Todisco Joseph | Chief Executive Officer | Sell | 37,443 | $5.30 | $198.4K | 0 |
| Nov 15, 2022↗ | Todisco Joseph | Chief Executive Officer | Buy | 20,000 | $3.82 | $76.4K | 0 |
| Aug 24, 2022↗ | Todisco Joseph | Chief Executive Officer | Buy | 4,700 | $3.92 | $18.4K | 0 |
| May 17, 2022↗ | Kaplan Myron | Director | Buy | 5,000 | $3.78 | $18.9K | 0 |
| May 16, 2022↗ | Todisco Joseph | Chief Executive Officer | Buy | 10,000 | $3.38 | $33.8K | 0 |
| Dec 6, 2021↗ | David Matthew T | Interim CEO and CFO | Buy | 2,000 | $4.50 | $9.0K | 0 |
| Nov 17, 2021↗ | David Matthew T | Interim CEO and CFO | Buy | 1,000 | $5.07 | $5.1K | 0 |
| Nov 16, 2021↗ | Kaplan Myron | Director | Buy | 10,000 | $5.14 | $51.4K | 0 |
| May 21, 2021↗ | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | Sell | 8,000 | $6.92 | $55.4K | 0 |
| May 17, 2021↗ | Kaplan Myron | Director | Buy | 15,000 | $6.03 | $90.5K | 0 |
CRMD Insider Buying Activity
The following table shows recent insider purchases of CorMedix Inc. (CRMD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 23, 2025↗ | Kaplan Myron | Director | Buy | 25,000 | $11.02 | $275.5K | 0 |
| Oct 31, 2024↗ | Mistry Erin | EVP, Chief Commercial Officer | Buy | 1,500 | $9.99 | $15.0K | 0 |
| Mar 13, 2024↗ | Todisco Joseph | Chief Executive Officer | Buy | 13,561 | $3.74 | $50.7K | 0 |
| Dec 14, 2023↗ | DUNTON ALAN W | Director | Buy | 6,000 | $3.38 | $20.3K | 0 |
| Nov 17, 2023↗ | Mistry Erin | Chief Commercial Officer | Buy | 1,000 | $4.00 | $4.0K | 0 |
| Sep 8, 2023↗ | Todisco Joseph | Chief Executive Officer | Buy | 10,000 | $3.71 | $37.1K | 0 |
| May 18, 2023↗ | Kaplan Myron | Director | Buy | 6,000 | $4.54 | $27.3K | 0 |
| Nov 15, 2022↗ | Todisco Joseph | Chief Executive Officer | Buy | 20,000 | $3.82 | $76.4K | 0 |
| Aug 24, 2022↗ | Todisco Joseph | Chief Executive Officer | Buy | 4,700 | $3.92 | $18.4K | 0 |
| May 17, 2022↗ | Kaplan Myron | Director | Buy | 5,000 | $3.78 | $18.9K | 0 |
| May 16, 2022↗ | Todisco Joseph | Chief Executive Officer | Buy | 10,000 | $3.38 | $33.8K | 0 |
| Dec 6, 2021↗ | David Matthew T | Interim CEO and CFO | Buy | 2,000 | $4.50 | $9.0K | 0 |
| Nov 17, 2021↗ | David Matthew T | Interim CEO and CFO | Buy | 1,000 | $5.07 | $5.1K | 0 |
| Nov 16, 2021↗ | Kaplan Myron | Director | Buy | 10,000 | $5.14 | $51.4K | 0 |
| May 17, 2021↗ | Kaplan Myron | Director | Buy | 15,000 | $6.03 | $90.5K | 0 |
CRMD Insider Selling Activity
The following table shows recent insider sales of CorMedix Inc. (CRMD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026↗ | Blum Susan | Chief Financial Officer | Sell | 9,767 | $7.27 | $71.0K | 0 |
| Jan 23, 2026↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 10,778 | $7.27 | $78.4K | 0 |
| Jan 23, 2026↗ | Todisco Joseph | Chief Executive Officer | Sell | 27,306 | $7.27 | $198.5K | 0 |
| Jan 23, 2026↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 8,803 | $7.27 | $64.0K | 0 |
| Jan 22, 2026↗ | Dillione Janet | director | Sell | 10,000 | $6.88 | $68.8K | 38,473 |
| Jan 21, 2026↗ | Dillione Janet | Director | Sell | 10,000 | $6.88 | $68.8K | 0 |
| Jan 12, 2026↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 5,794 | $7.15 | $41.4K | 0 |
| Jan 12, 2026↗ | Todisco Joseph | Chief Executive Officer | Sell | 40,082 | $6.94 | $278.2K | 0 |
| Jan 2, 2026↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 10,895 | $12.16 | $132.5K | 0 |
| Jan 2, 2026↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 11,333 | $12.16 | $137.8K | 0 |
| Dec 30, 2025↗ | DUNTON ALAN W | Director | Sell | 20,000 | $13.00 | $260.0K | 0 |
| Dec 18, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 30,000 | $12.00 | $360.0K | 0 |
| Dec 9, 2025↗ | Dillione Janet | Director | Sell | 34,000 | $12.00 | $408.0K | 0 |
| Dec 9, 2025↗ | Lefkowitz Steven W | Director | Sell | 40,000 | $11.88 | $475.2K | 0 |
| Dec 2, 2025↗ | Dillione Janet | Director | Sell | 46,657 | $10.00 | $466.6K | 0 |
| Nov 24, 2025↗ | Dillione Janet | Director | Sell | 26,343 | $9.93 | $261.6K | 0 |
| Nov 14, 2025↗ | Dillione Janet | Director | Sell | 30,000 | $11.42 | $342.6K | 0 |
| Sep 12, 2025↗ | DUNTON ALAN W | Director | Sell | 10,000 | $13.13 | $131.3K | 0 |
| Sep 12, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 50,000 | $13.00 | $650.0K | 0 |
| Sep 9, 2025↗ | Hurlburt Elizabeth | Chief Operating Officer | Sell | 53,997 | $13.18 | $711.8K | 0 |
| Sep 9, 2025↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 50,000 | $13.41 | $670.3K | 0 |
| May 10, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 21,225 | $11.66 | $247.5K | 0 |
| Jan 17, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 23,977 | $12.17 | $291.8K | 0 |
| Jan 10, 2025↗ | David Matthew T | Chief Financial Officer | Sell | 6,515 | $11.19 | $72.9K | 0 |
| Jan 10, 2025↗ | Hurlburt Elizabeth | EVP | Sell | 5,790 | $11.19 | $64.8K | 0 |
| Jan 10, 2025↗ | Mistry Erin | EVP, Chief Commercial Officer | Sell | 5,689 | $11.19 | $63.7K | 0 |
| Jan 10, 2025↗ | Todisco Joseph | Chief Executive Officer | Sell | 17,829 | $11.19 | $199.5K | 0 |
| Jan 2, 2025↗ | David Matthew T | Chief Financial Officer | Sell | 8,648 | $8.22 | $71.1K | 0 |
| Jan 2, 2025↗ | Hurlburt Elizabeth | EVP | Sell | 11,378 | $8.22 | $93.5K | 0 |
| Jan 2, 2025↗ | Mistry Erin | EVP, Chief Commercial Officer | Sell | 7,830 | $8.22 | $64.4K | 0 |
| Jan 2, 2025↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 11,844 | $8.22 | $97.4K | 0 |
| Dec 12, 2024↗ | Zelnick Kaufman Beth | Chief Legal Officer | Sell | 6,044 | $8.77 | $53.0K | 0 |
| Nov 14, 2024↗ | Hurlburt Elizabeth | EVP | Sell | 140,027 | $11.18 | $1.57M | 0 |
| May 10, 2024↗ | Todisco Joseph | Chief Executive Officer | Sell | 26,982 | $5.17 | $139.5K | 0 |
| Jan 12, 2024↗ | David Matthew T | Chief Financial Officer | Sell | 5,216 | $3.47 | $18.1K | 0 |
| Jan 12, 2024↗ | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | Sell | 4,603 | $3.47 | $16.0K | 0 |
| Jan 12, 2024↗ | Mistry Erin | Chief Commercial Officer | Sell | 4,389 | $3.47 | $15.2K | 0 |
| Jan 12, 2024↗ | Todisco Joseph | Chief Executive Officer | Sell | 13,781 | $3.47 | $47.8K | 0 |
| May 10, 2023↗ | Todisco Joseph | Chief Executive Officer | Sell | 37,443 | $5.30 | $198.4K | 0 |
| May 21, 2021↗ | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | Sell | 8,000 | $6.92 | $55.4K | 0 |
CRMD Insiders
Similar Stocks to CRMD
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B